Early-life events may trigger biochemical pathways for Alzheimer’s disease: the “LEARn” model

被引:0
|
作者
Debomoy K. Lahiri
Nasser H. Zawia
Nigel H. Greig
Kumar Sambamurti
Bryan Maloney
机构
[1] Indiana University School of Medicine,Department of Psychiatry, Institute of Psychiatric Research
[2] University of Rhode Island,Department of Biomedical and Pharmaceutical Sciences
[3] National Institute of Aging,Laboratory of Neurosciences, Intramural Research Program
[4] NIH,Department of Physiology and Neuroscience
[5] Medical University of South Carolina,undefined
来源
Biogerontology | 2008年 / 9卷
关键词
Latency; Gene regulation; Methylation; Epigenetic; Amyloid; Lead; Pb;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD), the most common form of dementia among the elderly, manifests mostly late in adult life. However, it is presently unclear when the disease process starts and how long the pathobiochemical processes take to develop. Our goal is to address the timing and nature of triggers that lead to AD. To explain the etiology of AD, we have recently proposed a “Latent Early-life Associated Regulation” (LEARn) model, which postulates a latent expression of specific genes triggered at the developmental stage. This model integrates both the neuropathological features (e.g., amyloid-loaded plaques and tau-laden tangles) and environmental factors (e.g., diet, metal exposure, and hormones) associated with the disease. Environmental agents perturb gene regulation in a long-term fashion, beginning at early developmental stages, but these perturbations do not have pathological results until significantly later in life. The LEARn model operates through the regulatory region (promoter) of the gene and by affecting the methylation status within the promoter of specific genes.
引用
收藏
相关论文
共 50 条
  • [31] Development of Alzheimer's disease and recent life stress events
    Reich, Edgardo
    Halac, Elena
    Torres, Carlos
    Rizzo, Antonella
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 184 - 184
  • [32] MRI measurements may indicate early Alzheimer's disease
    Anon
    Biophotonics International, 2002, 9 (06):
  • [33] The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease
    Zhang, Xingyu
    Fu, Zhihui
    Meng, Lanxia
    He, Mingyang
    Zhang, Zhentao
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [34] Does Alzheimer's disease start early in life?
    Ohm, TG
    MOLECULAR PSYCHIATRY, 1997, 2 (01) : 21 - 25
  • [35] Does Alzheimer's disease start early in life?
    T G Ohm
    Molecular Psychiatry, 1997, 2 : 21 - 25
  • [36] Adverse events and dropouts in Alzheimer's disease studies: What can we learn?
    Henley, David B.
    Sundell, Karen L.
    Sethuraman, Gopalan
    Schneider, Lon S.
    ALZHEIMERS & DEMENTIA, 2015, 11 (01) : 24 - 31
  • [37] Early-life exposures and Johne's disease risk in zoo ruminants
    Burgess, Tristan L.
    Witte, Carmel L.
    Rideout, Bruce A.
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2018, 30 (01) : 78 - 85
  • [38] The "LEARn" (Latent Early-Life Associated Regulation) Model: An Epigenetic Pathway Linking Metabolic and Cognitive Disorders
    Lahiri, Debomoy K.
    Maloney, Bryan
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 : S15 - S30
  • [39] Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease
    Talwar, Puneet
    Kushwaha, Suman
    Gupta, Renu
    Agarwal, Rachna
    FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [40] Breaking Patterns of Disease Early-Life Clues May Predict Long-Term Health
    Mead, M. Nathaniel
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2010, 118 (08) : A352 - A352